(-0.12%) 5 462.77 points
(-0.08%) 39 080 points
(0.12%) 17 738 points
(-0.66%) $80.30
(-4.32%) $2.64
(-0.78%) $2 312.60
(0.13%) $28.91
(2.33%) $1 009.40
(0.28%) $0.936
(0.71%) $10.68
(0.48%) $0.792
(-0.16%) $87.35
Live Chart Being Loaded With Signals
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company\'s lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain...
Stats | |
---|---|
Today's Volume | 500 |
Average Volume | 5 340 |
Market Cap | 41.00M |
EPS | $-0.210 ( Q1 | 2024-05-31 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.410 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-06 | Melnik Serguei | Sell | 5 000 | Common Stock, par value $0.001 per share |
INSIDER POWER |
---|
-100.00 |
Last 1 transactions |
Buy: 0 | Sell: 5 000 |
Nutriband Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nutriband Inc. Financials
Annual | 2023 |
Revenue: | $2.09M |
Gross Profit: | $818 893 (39.27 %) |
EPS: | $-0.690 |
FY | 2023 |
Revenue: | $2.09M |
Gross Profit: | $818 893 (39.27 %) |
EPS: | $-0.690 |
FY | 2022 |
Revenue: | $2.08M |
Gross Profit: | $750 409 (36.08 %) |
EPS: | $-0.570 |
FY | 2022 |
Revenue: | $1.42M |
Gross Profit: | $504 310 (35.46 %) |
EPS: | $-1.060 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company\'s lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators